Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Clinical trial NCT02448810 · TERMINATED
Trial details
- NCT number
- NCT02448810
- Sponsor
- Baxalta now part of Shire
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2017-02-15
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.